Clinicians & Researchers

You are here

Who We Are

The Clinical Trials Network for the Prevention and Early Treatment of Acute Lung Injury (PETAL Network) is a network of 12 Clinical Centers (CC) and 1 Clinical Coordinating Center (CCC) funded by the National Heart, Lung, and Blood Institute (NHLBI) to develop and conduct randomized controlled clinical trials to prevent Acute Respiratory Distress Syndrome (ARDS) or provide early treatment to improve the outcome of patients who have ARDS. The PETAL Network is seeking your input and feedback.


Jun 8, 2023

It is with the heaviest of hearts and deepest sorrow that the PETAL Network notes the passing of CCC Biostatistician Douglas Hayden on June 2, 2023.

His obituary can be found on Boston Cremation.

Feb 9, 2022

NHLBI PETAL Network ends Phase 3 sepsis trial early

PETAL Network study found no significant difference in 90-day mortality rates, nor safety concerns, after providing patients with one of two common treatment strategies

Jun 22, 2020

Major US Trial Closes Showing No Benefit for Hydroxychloroquine in COVID-19

June 20, 2020